Skip to main content
. 2006 Feb;77(2):203–207. doi: 10.1136/jnnp.2005.072355

Table 2 Major groups of diseases stratified for sex and age at death, comparison between patients with MG and matched controls.

Age at death Male patients (n = 100) Male controls (n = 500) p Female patients (n = 149) Female controls (n = 745) p
Respiratory tract disease
 0–29 years 0/2 0/10 1/4 (25.0) 0/14 0.05
 30–49 years 3/6 (50.0) 1/25 (4.0) 0.003* 4/22 (18.2) 4/50 (8.0) 0.21
 50–69 years 12/36 (33.3) 14/127 (11.0) 0.001* 14/48 (29.2) 24/179 (13.4) 0.009*
 ⩾70 years 20/56 (35.7) 89/338 (26.3) 0.15 16/75 (21.3) 128/502 (25.5) 0.44
 Total 35/100 (35.0) 104/500 (20.8) 0.002* 35/149 (23.5) 156/745 (20.9) 0.49
Cardiac disease
 0–29 years 0/2 0/10 0/4 1/14 (7.1) 0.58
 30–49 years 0/6 8/25 (32.0) 0.11 2/22 (9.1) 6/50 (12.0) 0.72
 50–69 years 7/36 (19.4) 66/127 (52.0) 0.001* 7/48 (14.6) 53/179 (29.6) 0.036*
 ⩾70 years 22/56 (39.3) 179/338 (53.0) 0.06 34/75 (45.3) 227/502 (45.2) 0.99
 Total 29/100 (29.0) 253/500 (50.6) <0.001* 43/149 (28.9) 287/745 (38.5) 0.026*
Malignant disease
 0–29 years 0/2 0/10 0/4 3/14 (21.4) 0.31
 30–49 years 0/6 3/25 (12.0) 0.37 1/22 (4.5) 23/50 (46.0) 0.001*
 50–69 years 4/36 (11.1) 36/127 (28.3) 0.034* 5/48 (10.4) 93/179 (52.0) <0.001*
 ⩾70 years 7/56 (12.5) 72/338 (21.3) 0.13 5/75 (6.7) 109/502 (21.7) 0.002*
 Total 11/100 (11.0) 111/500 (22.2) 0.011* 11/149 (7.4) 228/745 (30.6) <0.001*
Cerebrovascular disease
 0–29 years 0/2 0/10 0/4 1/14 (7.1) 0.58
 30–49 years 1/6 (16.7) 2/25 (8.0) 0.52 0/22 5/50 (10.0) 0.12
 50–69 years 1/36 (2.8) 15/127 (11.8) 0.11 3/48 (6.3) 17/179 (9.5) 0.48
 ⩾70 years 10/56 (17.9) 66/338 (19.5) 0.77 10/75 (13.3) 121/502 (24.1) 0.038*
 Total 12/100(12.0) 83/500 (16.6) 0.25 13/149 (8.7) 144/745 (19.3) 0.002*

The fraction, as well as the percentage (in brackets), shows the occurrence of the disease compared with all deceased individuals of the same sex who died in the same time period. * Pearson x2 tests were used. Statistical significance.